MedTrace Logo

Chiropractic Spinal Manipulative Therapy for Acute Neck Pain

NCT05374057 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2023-08-08

No results posted yet for this study

Summary

Acute neck is very common in the general population and often causes disability over shorter or longer time periods. Unfortunately, the efficacy of chiropractic spinal manipulative therapy (CSMT) and the efficacy of Non-steroidal Anti-inflammatory Drugs (NSAIDs) on acute neck pain is unknown. This 4-arm randomized controlled trial (RCT) will likely provide evidence for the efficacy of CSMT as well as NSAIDs. The applied methodology of the study will aim towards the highest research standards possible for manual-therapy RCTs, thus avoiding typical methodological shortcomings from previous manual-therapy studies. Our aim is to establish evidence-based knowledge on the efficacy of CSMT and NSAIDs in the treatment of acute neck pain.

Conditions

  • Acute Neck Pain

Interventions

OTHER

Chiropractic spinal manipulative therapy (CSMT)

See study arm.

OTHER

CSMT sham manipulation

See study arm.

DRUG

Ibuprofen

See study arm.

DRUG

Placebo medication

See study arm.

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER

  • The Dam Foundation

    collaborator OTHER

  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Michael B. Russell, Professor · Division for Research and Innovation, Akershus University Hospital, Norway

  • Aleksander Chaibi, PhD · Institute for Health and Society, Faculty of Medicine, University of Oslo, Norway

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-23
Primary Completion
2023-12-31
Completion
2024-08-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05374057 on ClinicalTrials.gov